The Duodenal Stent Market is expected to register a CAGR of 5.7% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Product Type (Metal Duodenal Stent, Polymer Duodenal Stent). The report further presents analysis based on the End User (Ambulatory Surgical Centers, Hospitals, Specialty Clinics). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Duodenal Stent Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Duodenal Stent Market Segmentation
Product Type- Metal Duodenal Stent
- Polymer Duodenal Stent
- Ambulatory Surgical Centers
- Hospitals
- Specialty Clinics
Strategic Insights
Duodenal Stent Market Growth Drivers- Rising Incidence of Duodenal Obstruction: The primary drivers of the duodenal stent market are the gradually increasing prevalence of duodenal obstructions, mostly resulting from cancers such as pancreatic, gastric, and colorectal cancers. Tumors within the abdomen can lead to the obstruction of the duodenum, thereby causing severe symptoms including nausea, vomiting, and weight loss. The rise in malignancy, particularly with respect to cancers of the gastrointestinal tract, will invariably affect stent requirements. Age at which elderly people are more likely to develop cancers associated with and affecting the gastrointestinal system would further add to this burden.
- Minimally Invasive Procedures: Adoption has been one of the most major market push factors for the less invasive procedures. Conventional surgical techniques in the treatment of duodenal obstruction are long-lasting in recovery and have more complications. However, duodenal stent insertions are less invasive and the hospital stay is shorter with fewer complications in comparison with other procedures. It increases adoption rates of clinical practice of the product due to such preferences.
- Betterment in technology in stent: Application of inventive materials, designs, and delivery systems in stents has further paved avenues for the growth of the duodenal stent market. Latest stents are close to being flexible and more durable, made of biocompatible material to relieve patients long-term and prevent stent migration or occlusion. It further includes the evolution of drug-eluting stents that release the duration of the intervention tubal re-narrowing caused under implantation thus improving clinical outcome and propelling future growth in the market.
- SEMS Growing Trend: Another key trend observed in the duodenal stent market has been the growing demand for self-expanding metallic stents (SEMS). Typically these are made up of materials, such as nitinol or stainless steel, and automatically expand after deployment, instantly relieving the obstructed area. They have been preferred over other varieties of stents due to their mechanical strength, facilitating ease of placement along with their ability to form within the curve of the duodenum. This is likely to persist since SEMS provide better patient care through fewer complications and higher patency rates of stented sites.
- Shift towards drug-eluting stents: Drug-eluting stents are stents coated with drugs to minimize the risk of complications and the risk of restenosis. It is another wave that is fast gaining traction in the already crowded market. The inclination in healthcare providers to opt for the drug-eluting stents instead of traditional stents is because of the improvement that will be made in long-term clinical outcomes and reduced recurrence rates. This phenomenon forms a part of the larger developments in medical technology relevant to enhancing care for the patient.
- Patient-centered treatment: The concept of treatment that arises in medical practice, including the use of a duodenal stent, is also patient-centered. It provides specialized solutions for each patient based on the condition, health status, and needs of the patient. Providers have shifted towards stents that are easily placed and have less risk for adverse events like migration or occlusion in pursuit of highest possible patient satisfaction and optimal treatment outcomes. The throw is personalization and patient centricity; this would be motivating for stent innovations in the duodenal arena.
- Advancements in Biodegradable Stents: Next in line is the biodegradable or bioabsorbable stent. The advantage of biodegradable stents is that they dissolve naturally within the human body with time, thus avoiding the need for removal interventions. A lot of potential exists in developing biodegradable stents as an opportunity to minimize long-term complications and have a more comfortable patient.
- Strategic alliances and acquisitions: Opportunity for the duodenal stent manufacturers to strategize on growth and development through strategic alliance or acquisition. Strategic alliances with the hospital or research institutes or with other manufacturers of medical devices can be harnessed to develop more sophisticated technology, which can expand the horizon of market exposure of the company. Mergers and acquisitions can avail new geography, new products, and distribution networks to the company, which help drive market growth overall.
- Growth of the Geriatric Population: The aging of the global population and the resultant increase in illnesses associated with the condition for which duodenal stents are used will be a source of more incidences. More individuals reaching advanced ages will become an added demand for medical interventions in the form of treating gastrointestinal obstructions. This is a long-term play for the duodenal stent market, as healthcare systems continue to seek to improve the quality of life for the elderly while bringing medical solutions to manage complex needs that this segment is bound to create.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Duodenal Stent Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Duodenal Stent Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Metal Duodenal Stent segment, by product type, dominated the market in 2023.
Players operating in the market are EndoChoice, Olympus Corporation, Merit Medical Systems, TaeWoong Medical, Cook Medical, Medtronic Plc., Becton, Dickinson and Company, Boston Scientific Corporation, Diagmed Healthcare, Ltd., Conmed Corporation
North America region dominated the Duodenal Stent market in 2023.
Advancements in Biodegradable Stents act as a opportunity for growth of the market in forecast period.
The Duodenal Stent Market is estimated to witness a CAGR of 5.7% from 2023 to 2031
The major factors driving the Duodenal Stent market are:
1. Rising Incidence of Duodenal Obstruction
2. Minimally Invasive Procedures
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Duodenal Stent Market

Apr 2024
Laser-Assisted ENT Surgeries Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)

Apr 2024
Mobile Cleanroom Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Softwall and Hardwall), End User (Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography

Apr 2024
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)

Apr 2024
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography

Apr 2024
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography

Apr 2024
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Apr 2024
Fall Management Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensor Pads, Floor Mat, Hip Protectors, Alert Systems, Communication Devices, and Other Products), Application (Fall Detection Systems, Fall Prevention Equipment, and Post-Fall Monitoring and Response Systems), Age Group [Elderly Population (65 and Above) and Adults (18–64 years)], End User (Hospitals and Clinics, Nursing Homes, Home Care Settings, and Other End Users), and Geography

Apr 2024
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)